Alaska Children's EYE & Strabismus
Anchorage, Alaska, 99508, United States
NCT Number: NCT04249505
Youth and some adults have photoscreening refractions and hand-held auto refraction before cycloplegia refraction during new and follow up eye examinations. Vector math is applied to each refraction to determine how closely the hand-held "dry" devices match actual refraction.
Looking for future studies?
Notify Me6 month–95 year
All sexes
Observational
Anchorage, Alaska, 99508, United States
A closeness-of-fit algorithm utilizing vector transformations of astigmatism is designed and applied to 50-years of clinical international refractive experience.
As a part of new and follow up comprehensive eye examinations, patients and parents consented to confirm the cycloplegic refraction to other portable refractive tools.
The ability of photoscreeners "2WIN" ("Adaptica," Padova italy), "PlusoptiX A12" (Nuremberg, Germany) and "Retinomax" (Righton, Tokyo, Japan) to match actual refraction is assessed utilizing the new algorithm.
This algorithm could then be applied to batches of donated spectacles distend by charitable organizations worldwide if portable auto refracting devices are employed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
non-cycloplegia refraction by Adaptica "2WIN"
non-cycloplegic refraction by "Plusoptix A12" photoscreener
non-cycloplegic refraction by "Retinomax K+" auto refractor
Time frame: 1 day
spherical equivalent
Time frame: 1 day
Vector transform J0 and J45 astigmatism
Time frame: 1 day
Spectacle comparison score (Percent similarity combined sphere-cylinder)
Time frame: 1 day
Spectacle similarity score striated by age relative to patient's ability to accommodate
Alaska Blind Child Discovery
Other
The Refractive Accuracy of Photoscreeners "2WIN" and "PlusoptiX" and the "Retinomax" Auto Refractor
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07478419
Astigmatism, Eye Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05957458
Amblyopia, Ametropia
Beijing, Haidian District, China
View Trial DetailsNCT04666870
Eye Diseases, Hyperopia
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT04820218
Astigmatism, Eye Diseases
Newark, California, United States
View Trial Details